Company News
Syncing Success: ALLpaQ & The PC Support Group
At ALLpaQ, we boast an unwavering commitment to quality – not only in our products but also in our people. […]
Dec 05th, 2023
The Medicine and Healthcare products Regulatory Agency has underscored the need for strong controls around extractables and leachables in pharmaceutical development.
Dr Melaine Pires, senior pharmaceutical assessor at the MHRA, outlined existing regulatory guidelines to delegates at the Disposable Solutions for Biomanufacturing Conference in Munich, Germany.
Risks surrounding extractables and leachables included interfering with drug efficacy.
As such, Dr Pires said discussions were underway to harmonise legislation in key drug development regions around the world.